More Than 60,000 PCR Tests In The Fight Against The Pandemic

Since the beginning of the Corona crisis, Bayer has been committed to fighting the pandemic and has provided medical expertise and resources worldwide. The tireless, voluntary commitment of the dedicated employees has already provided important contributions.

Since the beginning of April, Bayer has been providing PCR testing (polymerase chain reaction) capacity for virus diagnostics at its Berlin site. In Berlin, a dedicated COVID-19 analysis laboratory was set up on two floors of a research building. 140 employees have voluntarily signed up for this work, have received special training, and since then have carried out up to 1,000 tests every day - more than 60,000 now. The test method was validated with the Robert Koch Institute, and tests are carried out at Bayer's expense in close cooperation with the Berlin-Brandenburg state laboratory.

"All colleagues working in the laboratory are volunteers and have been exempt from their regular duties for this project. The equipment required for the SARS-CoV-2-tests comes from all areas of research and development at Bayer," reports Dr. Thomas Zollner, head of the Berlin laboratory, who is otherwise responsible for the therapeutic area of endocrinology, metabolism and reproductive health.

For several months now, numerous employees from various departments have been voluntarily supporting the fight against the virus worldwide. Bayer also participates in several initiatives, such as the COVID-19 Therapeutic Accelerator Initiative of the Bill and Melinda Gates Foundation, where the company makes part of its compound library available for research purposes.

The strong commitment of all volunteering Bayer employees has recently been honored with the Responsible Care Award - a prize awarded by the European Chemical Council (Cefic) for Bayer's outstanding performance in the fight against the pandemic.